Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Non-metastatic Prostate Cancer × darolutamide × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 9 Non-metastatic Castration-resistant Prostate Cancer 3 Neoplasm Metastasis 2 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 2 Urogenital Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Non-metastatic Prostate Cancer 1 Metastatic Hormone-sensitive Prostate Cancer 1 Fatigue 1 Depression 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Advanced Prostate Carcinoma 1

Interventions

enzalutamide 1 darolutamide 1 apalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06204302 2024-04-09

ARENA

Bayer

Non-metastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡